Perspective Therapeutics

Perspective Therapeutics

CATX· Manufacturing· Fiscal year ends in December

CEO pay in FY2025

Johan (Thijs) Spoor is the CEO of Perspective Therapeutics and was paid $2.4M in FY2025 (Dec).

PayNo stock prices for these years
CEO pay is from each Perspective Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Johan (Thijs) SpoorFY2025
  2. 2Juan GrahamFY2025
  3. 3Joel SendekFY2025
  4. 4Markus Puhlmann, M.D.FY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Perspective Therapeutics paid its 4 named executives $7.7M in total in FY2025 (Dec). CEO Johan (Thijs) Spoor was paid $2.4M of that.

Name
Johan (Thijs) SpoorCEO and DirectorNot disclosed
Juan GrahamFormer Chief Financial Officer5Not disclosedNot disclosed
Joel SendekChief Financial Officer4Not disclosedNot disclosed
Markus Puhlmann, M.D.Chief Medical Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers21

See all

The FY2025 (Dec) proxy of Perspective Therapeutics names 21 peer companies for pay. Among Perspective Therapeutics and these peers, CEO pay was the lowest of 10 and total shareholder return was 5th highest of 9.

10th highest of 10in Perspective Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$2.4M$27.8M

5th highest of 9in Perspective Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$20$1,020

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Activity

Filings6

See all
Proxy statementDEF 14AApr 16, 2026FY2025
Annual report10-KMar 16, 2026FY2025
Proxy statementDEF 14AApr 16, 2025FY2024
Annual report10-KMar 26, 2025FY2024
Proxy statementDEF 14AApr 18, 2024FY2023
Annual report10-KMar 28, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data